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Abstract
Intestinal commensal bacteria have recently been shown to trigger macrophages to produce diffusible clastogens
(or chromosome-breaking factors) through a bystander effect (BSE) that mediates DNA damage and induces
chromosomal instability in neighboring cells. Colon macrophages appear central to colon carcinogenesis and
BSE through the expression of tumor necrosis factor–α (TNF-α) and cyclooxygenase-2 (COX-2). The former induces
netrin-1, a regulator of intestinal epithelial cell apoptosis, and the latter generates trans-4-hydroxy-2-nonenal
(4-HNE), an endogenous mutagen. To test whether colon macrophages are key effectors for BSE, we depleted
these cells in interleukin-10 knockout mice colonized with Enterococcus faecalis using encapsulated liposomal
clodronate (ELC), a bisphosphonate that causes macrophage apoptosis. We observed that E. faecalis polarizes
colon macrophages to an M1 phenotype. In addition, depleting these cells suppressed COX-2 and TNF-α,
blocked the formation of 4-HNE protein adducts, and inhibited up-regulation of netrin-1—all markers for BSE.
Finally, treatment with ELC prevented colitis, β-catenin activation, and cancer formation. These results show
that selected human commensals can polarize colon macrophages to the M1 phenotype and, when activated,
serve as the key effector for bacterial-induced BSE. Our findings suggest that depleting M1-polarized macro-
phages is a mechanism for the chemopreventive activity of bisphosphonates and that it represents a new
strategy for preventing colon cancer induced by intestinal commensals.
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Introduction
Inflammatory tissue microenvironments and immune cells control-
ling inflammatory responses are widely appreciated as key drivers
for colon carcinogenesis [1,2]. These cells include macrophages,
mast cells, dendritic cells, T cells, and natural killer cells among others
[3–10]. The pro-inflammatory and anti-inflammatory properties of
macrophages in particular have been characterized with evidence that
they can enhance invasion, suppress antitumor immunity, and pro-
mote carcinogenesis through vascular endothelial, platelet-derived,
and fibroblast growth factors, and transforming growth factor–β
[1,2]. Finally, Wnt/β-catenin signaling in epithelial cells—a hallmark
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of colon carcinogenesis—is also important to the regulation of inflam-
matory responses by macrophages [11,12].
Tissue macrophages are polarized by local environmental cues into
distinct M1 or M2 phenotypes [13]. Classically, the M1 state is
induced by bacterial antigens, interferon-γ, and tumor necrosis
factor–α (TNF-α) and renders macrophages microbicidal and tumor-
icidal. M1-polarized cells release nitric oxide and inflammatory cyto-
kines that promote differentiation of Th1 and Th17 T helper cells.
In contrast, M2-polarized (or regulatory) macrophages are generated
by anti-inflammatory factors such as interleukin-10 (IL-10), IL-13,
IL-4, IL-1ra, and transforming growth factor–β. These cells are con-
sidered alternatively activated and metabolize arginine to polyamines,
release anti-inflammatory cytokines that contribute to immune toler-
ance, angiogenesis, and tissue remodeling, and, in association with
solid tumors, promote malignancy.
In the colon, intestinal macrophages are most commonly consid-
ered innate immune cells that sample the commensal microbiota to
assure tolerance and prevent infection by exogenous pathogens [14].
Interactions between macrophages and the intestinal microbiota,
however, have become ever more important to understand because
commensal bacteria are increasingly recognized as important co-
factors in colon carcinogenesis [15]. We recently reported that intesti-
nal commensal bacteria can trigger macrophages to produce diffusible
clastogens (or chromosome-breaking factors) through a bystander effect
(BSE) that mediates DNA damage and induces chromosomal insta-
bility in neighboring cells [16,17]. Cyclooxygenase-2 (COX-2), a target
for drugs that can prevent colon cancer [18,19], is closely linked to
BSE [16,20]. Although downstream products from COX-2 such as
prostaglandin E2 have pro-proliferative and anti-apoptotic properties
that contribute to tumor growth [21], this enzyme also generates
diffusible mediators for BSE [22,23]. One such product, trans-4-
hydroxy-2-nonenal (4-HNE), is a mutagen that can modify proteins,
phospholipids, and DNA to form damaging adducts [17,22,24,25]. In
addition, 4-HNE can induce COX-2 to maintain enzymatic pro-
duction through positive feedback [26]. Of note, macrophages in pre-
neoplastic colon adenomas commonly express COX-2 [27]. These
same cells express inducible nitric oxide synthase (iNOS), which
implies an M1 phenotype [28].
TNF-α is expressed by colon macrophages and represents another
key mediator for BSE. This inflammatory cytokine has been asso-
ciated with chromosomal instability and the up-regulation of netrin-1,
an anti-apoptotic ligand [29,30]. Netrin-1 is secreted by intestinal epi-
thelial cells and binds dependence receptors (e.g., Deleted in Colorectal
Cancer and UNC5 homologs) that serve to regulate epithelial cell
apoptosis [31]. When overexpressed, or when cognate receptors are
lost, the ligand promotes colon cancer [32,33]. In the IL-10 knockout
model of colitis and cancer [34], the human intestinal commensal
Enterococcus faecalis activates colon macrophages to express COX-2
and TNF-α that mediate BSE and promote carcinogenesis
[16,17,24,30]. We hypothesized that if colon macrophages were solely
responsible for BSE, then selective depletion of these cells should
eliminate biologic markers for BSE and thereby protect against cancer.
To test this hypothesis, we colonized IL-10 knockout mice with
E. faecalis and depleted colon macrophages using encapsulated lipo-
somal clodronate (ELC). Clodronate is a non-nitrogenous bisphos-
phonate that selectively targets macrophages and has been used to
prevent colitis and cancer in murine models [35,36]. ELC, when
administered per rectum, is phagocytosed by macrophages with
clodronate released into the cytosol where it is enzymatically
converted to a nonhydrolyzable ATP analog—adenosine 5′-(β,γ-
dichloromethylene) triphosphate—that enters mitochondria to
depolarize inner membranes and induce apoptosis [37]. Of interest,
multiple large cohort and case-control studies show that bisphos-
phonate use in humans is associated with a significant reduction in
the risk for colon cancer [38,39].
To further establish the role of colon macrophages in E. faecalis–
induced BSE and carcinogenesis, we found that these cells were polar-
ized in Il10−/−mice to anM1 phenotype. Depleting colonmacrophages
using ELC suppressed TNF-α and COX-2, blocked the formation of
4-HNE protein adducts, and inhibited up-regulation of netrin-1—all
markers for BSE—and prevented cancer formation. These findings
show that selected human commensals can chronically polarize colon
macrophages to an M1 state where the phenotype generates bacterial-
induced BSE. Our findings suggest that depleting M1-polarized
macrophages is a mechanism for the chemopreventive activity of
bisphosphonates and that it represents a new strategy for preventing
colon cancer induced by intestinal commensals.
Materials and Methods
Bacteria and Mice
E. faecalis strain OG1RFSS is a spontaneously derived isolate of
OG1RF [40], a human oral commensal [41]. This strain is resistant
to streptomycin and spectinomycin and was grown as previously de-
scribed [16]. Conventionally housed and specific pathogen-free
C57BL/6 Il10+/+ (i.e., wild-type) and Il10−/− mice were purchased
from Jackson Laboratory (Bar Harbor, ME). All animal experiments
were performed at Oklahoma City Veterans Affairs Medical Center
Animal Research Facility. Protocols were approved by the University of
Oklahoma Health Sciences Center and Oklahoma City Department of
Veterans Affairs animal studies committees.
ELC and Control Liposomes
ELC and sham liposomes (SL) were purchased from Encapsula
NanoSciences (Nashville, TN). To limit the systemic effects of clod-
ronate on the immune system during a long-term experiment, ELC
was administered topically to the colonic mucosa through rectal
enema. To determine the optimal dose of ELC for depleting colon
macrophages, 0, 50, 100, and 200 μl were administered weekly per
rectum to Il10−/− mice (three mice per dose) using inhaled isoflurane
for sedation. All doses were well tolerated. After 6 weeks, colons were
removed at necropsy, fixed, and immunohistochemically stained for
macrophages using anti-F4/80 antibody (see below). Both 100- and
200-μl doses depleted colon macrophages by >90% (data not
shown). As a consequence, 100 μl was selected as the dose for enemas
in subsequent experiments. Enemas using ELC or SL were begun
2 weeks before colonization with OG1RFSS, or phosphate-buffered
saline (PBS) sham, and continued weekly thereafter for 9 months at
which time necropsies were performed.
The experiment was designed considering genotype, colonization,
and enemas as independent variables. We sought the minimal number
of control groups that would allow monitoring of the effect of geno-
type (i.e., wild type vs IL-10 knockout), colonization (E. faecalis–
colonized vs sham-colonized), and enema (ELC vs SL) on induction of
colitis and cancer. Mice were divided into four groups: 1) OG1RFSS-
colonized Il10+/+ mice that were administered ELC (n = 9); 2) sham-
colonized Il10−/− mice that were administered ELC (n = 9);
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3) OG1RFSS-colonized Il10−/− mice that were administered SL (n =
12); 4) OG1RFSS-colonized Il10−/− mice that were administered
ELC (n = 12).
Colonization with E. faecalis or Sham
ColonizationwithE. faecalis or PBS shamwas performed as previously
described [30]. In a single long-term experiment, 10-week-oldmalemice
were orogastrically administered with 1 × 109 colony forming units of
E. faecalis strainOG1RFSS or PBS as control. ForOG1RFSS-colonized
mice, high-density fecal colonization at an average of 109 colony forming
units per gram developed within 1 week. Colonization was maintained
by providing water containing streptomycin (500 mg/l) and spectino-
mycin (500 mg/l) throughout the 9-month experiment. OG1RFSS
was never recovered from fecal pellets of mice given PBS sham.
Figure 1. Depleting colonmacrophages with ELC suppresses inflammation and prevents cancer in Il10−/−mice colonized with E. faecalis.
(A) Immunohistochemical staining of colon biopsies using anti-F4/80 antibody (brown) shows few cells in the lamina propria of wild-type
mice (i.e., Il10+/+) colonized with E. faecalis and administered ELC (n = 9). (B) Staining of sham-colonized Il10−/− mice administered
ELC also show fewmacrophages (n= 9). (C) Numerous macrophages are present in colon biopsies from E. faecalis–colonized Il10−/−mice
administered SL (n= 12). (D) Macrophage staining is infrequent in E. faecalis–colonized Il10−/−mice administered ELC (n= 12). (E) Macro-
phages in the lamina propria of colon biopsies from E. faecalis–colonized Il10−/−mice administered SL are positive for iNOS, suggesting that
E. faecalis polarized these cells to an M1 phenotype. (F) Staining of biopsies in E for arginase is negative and consistent with the M1
polarization of macrophages. (G) Colon macrophages for mice administered ELC are significantly lower than for mice given SL (***P <
.001). (H) Inflammatory scores are significantly lower for colon biopsies from E. faecalis–colonized and sham-colonized Il10−/−mice admin-
istered ELC compared to SL-treated mice (***P < .001 and **P < .01, respectively); among ELC-treated mice, inflammation scores are
higher for sham-colonized Il10−/− mice compared to E. faecalis–colonized mice (***P < .001); more colon cancers are seen in SL-treated
and E. faecalis–colonizedmice than similarly colonized and ELC-treatedmice (micewith cancer indicated by crossed closed circles; P< .05).
All photomicrographs are ×20.
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Immunohistochemistry
At necropsy, colon biopsies were fixed with 10% PBS-buffered
formalin, stored in 70% ethanol, and embedded in paraffin. Biopsies
were obtained using a ×10 magnifying glass to identify areas of
potential pathology in the rectum and distal, middle, and proximal
colons. Four samples were obtained from each mouse with each
sample from approximately the same area of the colon. Cross sections
were stained with hematoxylin and eosin or mounted unstained for
immunohistochemical study. Immunohistochemical staining was
performed as previously described [17,24]. Epitope retrieval was
done by incubating sections in 10 mM sodium citrate buffer (pH 6.0)
for 20 minutes at 95°C. Primary antibodies for murine macrophages
(F4/80), TNF-α, and mouse dendritic cell marker (33D1) antibodies
were purchased from eBioscience (San Diego, CA). COX-2 and
netrin-1 antibodies were purchased from Santa Cruz Biotechnology
(Santa Cruz, CA). Other reagents included antibodies to mast cell
tryptase (Thermo Scientific, Rockford, IL), 4-HNE protein adducts
(Alpha Diagnostic International, San Antonio, TX), and active β-catenin
(Millipore, Temecula, CA).HRP goat anti-rabbit IgG conjugate (Invitrogen,
Camarillo, CA), HRP rabbit anti-goat IgG conjugate (Santa Cruz
Biotechnology), and HRP goat anti-rat IgG conjugate (Millipore) were
used as secondary antibodies. All antibodies were diluted as per the
manufacturers’ recommendations. Chromogenic development was per-
formed using DAB-enhanced liquid substrate with nuclei counterstained by
Mayer’s hematoxylin solution (Sigma, St Louis, MO). The number of
macrophages (F4/80), dendritic cells (33D1), and mast cells (mast cell
Figure 2. Effect of ELC treatment on colonic dendritic cells and mast cells. (A) Immunohistochemical staining of colon biopsies for
mouse dendritic cell marker (33D1) is negative for wild-type mice colonized with E. faecalis and administered ELC (n = 9). (B–D) Few
33D1-positive cells are seen in colon biopsies for Il10−/− mice (red arrows). (E) Average number of 33D1-positive cells per ×20 field
across Il10−/− groups (NS, not significant). (F) Immunohistochemical staining of colon biopsies for mast cell tryptase shows few cells
from biopsies of wild-type mice colonized with E. faecalis and administered ELC. (G) Increased mast cell staining is seen in biopsies for
sham-colonized Il10−/− mice administered ELC (n = 9). (H) Larger increase in mast cell staining is noted in biopsies for E. faecalis–
colonized Il10−/− mice administered SL (n = 12). (I) Depleting macrophages with ELC decreases mast cell staining in biopsies for
E. faecalis–colonized Il10−/− mice (n = 12). (J) Average number of mast cells per ×20 field across groups (NS, not significant; ***P <
.001). All photomicrographs are ×20.
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Figure 3. Depleting colonmacrophages is associatedwith reducedCOX-2 expression. (A) Immunohistochemical staining showsnoCOX-2 in
colon biopsies in wild-type mice colonized with E. faecalis and administered ELC. (B) COX-2 expression is noted for sham-colonized Il10−/−
mice administered ELC. (C) IncreasedCOX-2 expression is seen for Il10−/−mice colonizedwith E. faecalis and administered SL. (D) Depleting
macrophages with ELC significantly decreases COX-2 expression for E. faecalis–colonized Il10−/−mice. All photomicrographs are ×20.
Figure 4. Depleting colon macrophages decreases 4-HNE protein adducts. (A) Immunohistochemical staining for 4-HNE protein adducts
was negative in colon biopsies from wild-type mice colonized with E. faecalis and administered ELC. (B) Slight staining is noted for 4-HNE
protein adducts in the lamina propria and epithelium for sham-colonized Il10−/−mice administered ELC. (C) Colon crypts (red arrow) and
lamina propria (green arrow) stain strongly for 4-HNE protein adducts for Il10−/−mice colonized with E. faecalis and administered SL. (D)
Staining for 4-HNE protein adducts is reduced for E. faecalis–colonized Il10−/− mice administered ELC. All photomicrographs are ×20.
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tryptase)was determined fromphotomicrographs of five randomly selected
×20 fields for each colon biopsy, and average numbers were calculated.
Scoring Colon Inflammation
Colon sections were scored from 0 to 4 based on the number of
inflammatory cells, decrease in goblet cells, mucosal thickening, sub-
mucosal infiltration, ulceration, reactive atypia, and dysplasia as pre-
viously described [24]. Inflammation scores were the summation of
all scores with the presence of cancer noted separately.
Statistics
The mean ± SD was calculated for all parameters determined.
Statistical significance for inflammatory scores for each group and
numbers of positive staining cells per ×20 field were evaluated using
analysis of variance. Comparisons among groups were performed
using one-way analysis of variance with nonparametric pairwise com-
parisons calculated using the Wilcoxon method (JMP version 9.0.0;
SAS Institute, Cary, NC). Comparisons between groups having
colon cancer were performed using a two-sided Fisher exact test.
P values < .05 were considered statistically significant.
Results
Depleting Macrophages Prevents E. faecalis–Induced
Inflammation and Colon Cancer in Il10−/− Mice
Because the activation of macrophages by E. faecalis initiates
inflammation and colon carcinogenesis through BSE [16,23,24,30],
we sought to directly test the role of these cells in carcinogenesis in vivo.
Il10−/− mice were administered ELC or SL weekly per rectum. After
9 months, immunohistochemical staining showed an approximately
15-fold decrease in colon macrophages by ELC compared to SL-treated
mice (Figure 1, A–D and G ). Macrophages in the lamina propria from
Il10−/− mice that were colonized with E. faecalis expressed iNOS
(Figures 1E and W1) but not arginase (Figures 1F and W2), suggesting
an M1 phenotype.
Colons from E. faecalis–colonized Il10−/− mice administered SL
showed severe inflammation compared to E. faecalis–colonized and
ELC-treated mice (11.5 ± 6.3 vs 0.0 ± 0.0; P = .0001; Figure 1, C ,
D, andH ). In the SL-treated group, colon cancer was observed in 5 of
12 (42%) biopsies. This frequency was similar to previous observa-
tions using this model [24,30]. As expected, E. faecalis–colonized
Il10+/+ mice treated with ELC showed few macrophages and had
no inflammation or pathology (Figure 1, A, E , and H ). Surprisingly,
Il10−/−mice that were sham-colonized and administered ELC showed
significantly higher inflammation scores than E. faecalis–colonized
Il10−/− mice similarly treated with ELC (5.6 ± 4.1 vs 0.0 ± 0.0; P =
.0004; Figure 1, H ), with one mouse having a high inflammation
score developing cancer. This observation suggested the presence of
an uncharacterized antibiotic-resistant intestinal commensal that
could promote bacterial-induced BSE but was suppressed or excluded
by E. faecalis. Characterization of the intestinal microbiota in this
control group, however, was not further investigated.
Effect of ELC on Dendritic and Mast Cells
Dendritic and mast cells contribute to inflammation, adenoma
formation, and carcinogenesis in colon cancer [4,7,42–44]. To
Figure 5. Depleting colon macrophages inhibits TNF-α production. (A) Immunohistochemical staining for TNF-α–positive cells is not
evident in colon biopsies from wild-type mice colonized with E. faecalis and administered ELC. (B) A few TNF-α–positive cells are noted
in the lamina propria of biopsies from sham-colonized Il10−/− mice administered ELC. (C) In contrast, numerous cells stain strongly for
TNF-α for E. faecalis–colonized Il10−/− mice administered SL. (D) Few TNF-α–positive cells are evident in the lamina propria of colons
from E. faecalis–colonized Il10−/− mice administered ELC. All photomicrographs are ×20.
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determine whether ELC altered these immune cells in colon biopsies,
we stained for them by immunohistochemistry. No dendritic cells
were observed in E. faecalis–colonized wild-type mice (Figure 2A)
and only one to two dendritic cells per ×20 field across all Il10−/−
groups (Figure 2, B–E ). The lack of differences in numbers of den-
dritic cells did not appear to support a role for these cells in promot-
ing colon cancer in this model.
We next stained for mast cells and, similar to dendritic cells, observed
few cells in Il10+/+ mice administered ELC (Figure 2, F and J ). How-
ever, significantly increased numbers of mast cells were noted among
Il10−/− mice with the greatest increase observed in E. faecalis–colonized
mice administered SL (Figure 2, G–J). Treatment of E. faecalis– and
sham-colonized Il10−/− mice with ELC reduced the number of mast
cells by 17- and 6.5-fold, respectively, compared to SL-treated mice
(P < .001; Figure 2J ). As suggested by others [4,45], these findings
suggest that macrophages help attract mast cells in this model.
COX-2 and 4-HNE Protein Adducts Are Decreased after
Macrophage Depletion
We have previously shown that E. faecalis–infected macrophages
produce 4-HNE, a mutagenic breakdown product of arachidonic acid
that causes DNA damage and chromosomal instability in a COX-2–
dependent manner [23,24]. To confirm that macrophages produce
this mutagen in vivo as a mediator for BSE, we stained colon biopsies
for COX-2 and 4-HNE protein adducts. Few macrophages were pos-
itive for COX-2 in colon biopsies from Il10+/+ mice treated with ELC
(Figure 3A). COX-2–positive cells were abundant in colon biopsies
from sham-colonized Il10−/− mice administered ELC (Figure 3B).
Finally, COX-2–positive cells were significantly increased in colon
biopsies from E. faecalis–colonized Il10−/−mice administered SL com-
pared to mice colonized with E. faecalis and treated with ELC (Fig-
ure 3, C and D).
Similarly, staining was sparse for 4-HNE protein adducts in colon
biopsies for wild-type mice colonized with E. faecalis and treated with
ELC (Figure 4A). Slight staining for 4-HNE protein adducts was
evident in colon biopsies from Il10−/− mice treated with ELC (Fig-
ure 4B). However, colon crypts and macrophages stained strongly for
4-HNE protein adducts in biopsies from E. faecalis–colonized Il10−/−
mice administered SL (Figure 4C ). In comparison, staining for 4-HNE
protein adducts in colon biopsies from E. faecalis–colonized Il10−/−
mice treated with ELC was negative (Figure 4D), implying that
depleting macrophages negated COX-2 expression and resulted in a
loss of 4-HNE as a mediator for BSE.
TNF-α and Netrin-1 Are Decreased after
Macrophage Depletion
In addition to generating 4-HNE in the Il10−/− model, E. faecalis–
infected macrophages also express TNF-α that serves to upregulate
netrin-1 expression in colon crypts [30]. This extracellular ligand acts
to delay apoptosis as epithelial cells migrate up the crypt. To deter-
mine whether macrophage depletion also resulted in the loss of
TNF-α–induced netrin-1 expression, we stained colon biopsies for
TNF-α and netrin-1. Again, few cells were positive for TNF-α in
wild-type mice colonized with E. faecalis and treated with ELC or
in sham-colonized Il10−/− mice administered ELC (Figure 5, A
and B ). In contrast, macrophages in E. faecalis–colonized Il10−/−
Figure 6. Depleting colon macrophages blocks TNF-α–induced netrin-1 expression. (A) Typical expression of netrin-1 (brown) in epithelial
cells is observed at the bottom of colon crypts for wild-type mice colonized with E. faecalis and administered ELC. (B) Similar staining is
noted for netrin-1 staining for sham-colonized Il10−/− mice administered ELC. (C) Colonic epithelial cells stain more strongly for netrin-1
in biopsies from E. faecalis–colonized Il10−/− mice administered SL. (D) ELC decreases netrin-1 staining in biopsies from E. faecalis–
colonized Il10−/− mice to levels similar to that found in wild-type mice colonized with E. faecalis. All photomicrographs at ×20.
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mice administered SL stained strongly for TNF-α (Figure 5C ).
Finally, no TNF-α–positive cells were seen in E. faecalis–colonized
Il10−/− mice administered ELC (Figure 5D).
We next investigated the effect of macrophage depletion on
netrin-1 expression since TNF-α promotes crypt hyperplasia by
inhibiting epithelial cell apoptosis through netrin-1. Consistent with
previous findings in this model [30], netrin-1 expression was observed
in the colon crypts of wild-type mice colonized with E. faecalis and
administered ELC (Figure 6A) and in sham-colonized Il10−/− mice
treated with ELC (Figure 6B). For E. faecalis–colonized Il10−/− mice
administered SL that developed severe inflammation and elongated
crypts, netrin-1 expression was markedly increased (Figure 6C ).
Depleting macrophages using ELC decreased netrin-1 production
in Il10−/− mice colonized with E. faecalis to levels that were similar
to wild-type mice or sham-colonized mice (Figure 6D). These obser-
vations show that by depleting colon macrophages netrin-1 expression
is left unchanged.
Macrophage Depletion Blocks Wnt/β-Catenin Signaling
Colon cancer was noted in five E. faecalis–colonized Il10−/− mice
administered SL and one sham-colonized mouse given ELC (Figures 1F
and 7A). Because Wnt/β-catenin signaling is a hallmark of colon cancer
and important regulator of inflammation [11,12], we stained biopsies
from SL-treated mice that had colon cancer for active (i.e., unphos-
phorylated) β-catenin and compared these findings to E. faecalis–
colonized Il10−/− mice administered ELC. Strong staining for active
β-catenin was noted in neoplastic epithelial cells and macrophages
in the SL-treated group (Figure 7B) but not in mice administered
ELC (Figure 7C ).
Discussion
BSE is characterized by genomic damage arising in target cells due to
diffusible clastogens that are generated by activated cells. Classically,
this phenomenon occurs after irradiating myeloid or mesenchymal
cells [46], although it can also occur, as we have shown [16,17],
when macrophages are chronically infected. Activation of macro-
phages by intestinal commensals like E. faecalis leads to chromosomal
instability in epithelial cells, crypt hyperplasia, decreased apoptosis,
and transformation [23,24,30,47]. In this study, we found that de-
pleting colon macrophages in Il10−/− mice colonized with E. faecalis
prevented inflammation and carcinogenesis. In addition, we found
that these macrophages were polarized to the M1 phenotype. When
these macrophages were depleted, the molecular markers for BSE,
namely, 4-HNE protein adducts, COX-2, TNF-α, and netrin-1,
were also reduced. These findings suggest that M1 colon macro-
phages in this model are the primary effector cells for bacterial-
induced BSE and carcinogenesis [24,30]. In contrast to the role of
M2-polarized (or tumor-associated) macrophages in promoting tumor
progression [13], our findings suggest that M1-polarized macrophages—
phagocytes that ordinarily help resolve acute infections—can initiate
cellular transformation through BSE when chronically activated. This
concept provides a mechanism for how bacterial infections that pro-
mote chronic inflammation are associated with an increased risk for
cancer [1].
Our findings are consistent with prior reports showing that Heli-
cobacter spp. can trigger macrophages in Il10−/− mice to express
interferon-γ [48]. This, along with the knowledge that Escherichia coli
can also cause colitis and colon cancer in Il10−/− mice [49], suggests
that induction of an M1 phenotype in these mice is unlikely to be
specific for E. faecalis. It also remains unclear whether Il10−/− mice
are able to induce macrophages with an M2 phenotype. This is an
area of ongoing investigation in our laboratory. Finally, iNOS expres-
sion by M1-polarized colon macrophages suggests nitric oxide as an
additional mediator of BSE along with COX-2 and TNF-α. This
radical could promote carcinogenesis by inducing pro-inflammatory
cytokines, including COX-2, and inactivating p53-mediated caspases
[50]. Any role for nitric oxide in tumor development, however, is
likely to be multifaceted, as this molecule is also associated with apop-
tosis and tumor regression.
Additional evidence for the role of macrophages in colon carcino-
genesis can be found in studies that show bisphosphonates, like
clodronate, block inflammation and prevent dysplasia and cancer
in dextran sulfate–induced models of colitis [36,51]. Similarly,
depleting colon macrophages with dichloromethylene-containing
microspheres prevents colitis and cancer in conventionally colonized
IL-10 knockout mice [52]. Finally, these animal models, along with
our findings, provide a plausible mechanism for the reduction in
colon cancer risk due to bisphosphonates that has been shown in
retrospective human studies [38,39].
Wnt/β-catenin signaling is a hallmark of colon carcinogenesis [12].
The nuclear translocation of β-catenin is an early event in human
Figure 7. Depleting colon macrophages inhibits Wnt/β-catenin signaling. (A) Hematoxylin and eosin staining shows typical cancer in
distal colon of an E. faecalis–colonized Il10−/− mouse administered SL at ×20 and ×40 (inset). (B) Immunohistochemical staining for
unphosphorylated (active) β-catenin shows strong signaling in neoplastic epithelial cells (green arrow) and inflammatory cells in the
lamina propria (red arrows) for Il10−/− mice colonized with E. faecalis and administered SL (×20 magnification). (C) No active β-catenin
is evident in biopsies from E. faecalis–colonized Il10−/− mice administered ELC (×20).
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colon cancer and models of colitis-associated or Adenomatous polyposis
coli–deficient neoplasia [53–57]. Moreover, activated macrophages,
COX-2, and TNF-α all promote Wnt/β-catenin signaling [11,58,59].
In this study, we found that depleting colon macrophages eliminated
β-catenin signaling in E. faecalis–colonized Il10−/− mice and link
macrophage-induced BSE to this paradigm.
We observed a significant decrease in mast cells when colon
macrophages were depleted in E. faecalis–colonized Il10−/− mice.
The loss of macrophages may have resulted in decreased tissue levels
of prostaglandin E2 or chemokine (C-C motif) ligand 2 (or mono-
cyte chemoattractant protein-1) that are known to attract mast cells
[45,60]. Alternately, a loss of macrophages may have perturbed mast
cell proliferation through CD4+Foxp3+ T regulatory cells [9]. How-
ever, we did not further investigate these hypotheses since the deple-
tion of mast cells in Il10−/− mice through KitW-sh/KitW-sh mutations
failed to alter the incidence or severity of Helicobacter-induced colitis
or cancer [61]. Thus, the reduction in mast cells seemed an unlikely
explanation for a lack of colitis or cancer in E. faecalis–colonized Il10−/−
mice administered ELC.
Dendritic cells, in a fashion similar to macrophages, have been
implicated in inflammatory bowel disease and colon cancer [7,62].
However, in the present study, regardless of colonization status or
presence or absence of colon macrophages, there was no difference
in the small numbers of dendritic cells observed in colon biopsies
across all groups of Il10−/− mice. In contrast to macrophages, these
cells seem to play no more than a minimal role in bacterial-induced
BSE in this model.
Il10−/− mice have proven to be a useful model for studying colon
carcinogenesis. This is true, in part, because IL-10 induces CD4+Foxp3+
T regulatory and myeloid-derived suppressor cells that inhibit macro-
phage function [63]. In addition, in a model of familial adenomatous
polyposis, IL-10 was necessary in order for CD4+Foxp3+ T regulatory
cells to inhibit intestinal polyps [9,10]. A loss of this potent immuno-
suppressive cytokine sensitizes mice to colitis and colon cancer when
monoassociated or colonized by specific triggers such as E. faecalis
[24,49,64]. E. faecalis, a human intestinal commensal, produces extra-
cellular superoxide when deprived of heme [65]. This pro-oxidant
physiology helps to activate macrophages to generate BSE in vitro
[16,17] and in vivo [24,30]. Although a case-control study in an elderly
cohort failed to find an association between human colonization with
these bacteria and colon adenomas or cancer, the lack of data in this
study on colonization density, and the discovery of marked instability
in enterococcal colonization over time, limited the conclusions [66]. In
contrast, E. faecalis colonization was associated with colorectal cancer
when the density of colonization in feces was measured by real-time
polymerase chain reaction [67]. Finally, among patients with colon
cancer, greater levels of serum antibody to E. faecalis have been noted
compared to Streptococcus gallolyticus subsp. gallolyticus (formerly,
Streptococcus bovis biotype I [68]), an intestinal commensal bacterium
that has been implicated in colon cancer–related infections [15,69].
Several pathologic features of the Il10−/− model are analogous to
those found in precursor lesions for human colon cancer. For example,
in human colon adenomas, macrophages commonly express TNF-α,
COX-2, and iNOS [27,28,70]. Similar molecular signatures were
evident in SL-treated Il10−/− mice colonized with E. faecalis. In addi-
tion, as noted in our study, human colon adenomas are rich in macro-
phages and mast cells [4,27]. The IL-10 knockout model may also
mimic human colon cancer through polymorphisms in the promoter
region for IL10. In one case-control study, single-nucleotide poly-
morphism promoter genotypes associated with a reduced expression
of IL10 mRNA showed a four- to five-fold increased risk for colon
cancer [71]. Finally, preventing inflammation and colon cancer in
Il10−/−mice by depleting macrophages with ELC, and thereby blocking
BSE, is a plausible mechanism for human studies that show bisphos-
phonates reduce the risk for colon cancer [38,39].
Despite these similarities, the intestinal pathology in the Il10−/−
model more closely mimics colitis-associated disease than human
sporadic colon cancer. Most notably, villous and tubular colon ade-
nomas do not develop as typically seen in human colon cancer [64].
In addition, unlike in humans, the use of COX-2 inhibitors in IL-10
knockout mice is not protective and paradoxically causes severe
colitis and potentiates premalignant changes [72]. Nonetheless, many
parallels between human colon cancer and Il10−/− mice render it a
powerful model with which to study basic mechanisms of bacterial-
induced carcinogenesis.
The approach to intestinal colonization used in this study relied
on orally administered (and nonabsorbable) antibiotics to maintain
high-density colonization with E. faecalis. Although antibiotics can
affect the normal intestinal microbiota, our conclusions on the role
of macrophages in bacterial-induced BSE remain sound because
these antibiotics were similarly administered to ELC- and SL-treated
mice. In addition, this approach relied on conventionally raised Il10−/−
mice, rather than gnotobiotic mice, which could be considered an
advantage since conventional mice do not show defects in intestinal
mucus as found in germ-free mice [73]. The loss of this barrier is not
reported for human colon adenomas and could alter bacterial-driven
carcinogenesis in mice by allowing luminal bacteria to come into direct
contact with epithelial cells that should otherwise be protected [74].
Although we did not evaluate gene expression, measuring cellular pro-
teins by immunohistochemistry using validated antibodies is well
accepted in clinical practice and has the advantage of allowing precise
spatial and cellular localization of these proteins. Finally, although these
findings are based on a single long-term experiment involving 42 mice,
the incidence of colitis and colon cancer in SL-treated Il10−/− mice was
similar to that previously reported [24,49,64] and included sufficient
replicates in each group such that highly significant differences were
found across groups.
In summary, our findings show that E. faecalis polarizes colon
macrophages to an M1 phenotype in the IL-10 knockout model
and that these cells are essential to the development of inflammation
and cancer. The reduction or elimination of markers for BSE, namely,
COX-2, TNF-α, netrin-1, and 4-HNE protein adducts, supports a
key role for these innate immune cells in generating BSE. Inhibiting
bacterial-induced BSE by depleting colon macrophages may provide a
mechanism for the chemopreventive activity of bisphosphonates
[38,39]. Interventions that block bacterial-induced M1 polarization
of macrophages or inhibit mediators of BSE will provide novel strat-
egies for preventing colon cancer.
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Figure W1. iNOS expression in colon macrophages indicates M1 polarization. (A) Few macrophages in the lamina propria in colon bi-
opsies from wild-type mice colonized with E. faecalis and administered ELC stain positive for iNOS (brown). (B) A limited number of
macrophages stain for iNOS in the lamina propria for sham-colonized Il10−/−mice administered ELC. (C) Numerous macrophages in the
lamina propria stain for iNOS in biopsies for E. faecalis–colonized Il10−/− mice administered ELC. All photomicrographs are ×20.
Figure W2. Lack of arginase 1 expression in colon macrophages is consistent with M1 polarization. (A) Immunohistochemical staining
for arginase 1 is infrequent in macrophages in the lamina propria of colon biopsies from wild-type mice colonized with E. faecalis and
administered ELC. (B) Similar staining is seen for sham-colonized Il10−/− mice administered ELC and (C) E. faecalis–colonized Il10−/−
mice administered ELC, indicating M1 polarization of macrophages. Of note, unidentified cells in the muscularis externa of biopsies
from E. faecalis–colonized Il10−/− mice administered ELC stain for arginase 1 (C, arrows). All photomicrographs are ×20.
